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Relevance of NF-kB and NRF2 transcription factors into
multiple myeloma pathophysiology – A preliminary study
Raquel Alves1,2,3, Ana Cristina Gonçalves1,2,3, Joana
Jorge1,2,3, Catarina Afonso4, Adriana Roque4, Artur Paiva2,5,
Letícia Ribeiro 2,4, Catarina Geraldes1,2,4, Ana Bela Sarmento-
Ribeiro1,2,3,4
1Laboratory of Oncobiology and Hematology and University
Clinic of Hematologly, Faculty of Medicine of University of
Coimbra, Portugal;2iCBR-Coimbra Institute for Clinical and
Biomedical Research – Area of Environment, Genetics and
Oncobiology (CIMAGO), Faculty of Medicine, University of
Coimbra and CIBB - Center for Innovative Biomedicine and
Biotechnology, University of Coimbra, Portugal;3CACC-Clini-
cal Academic Center of Coimbra, Portugal;4Clinical Hematology
Department, Centro Hospitalar e Universitário de Coimbra,
Portugal;5Flow Cytometry Operational Management Unit,
Clinical Pathology Service, Centro Hospitalar e Universitário
de Coimbra, Portugal.
Multiple myeloma (MM) is a mature B cell dyscrasia
characterized by an abnormal proliferation of monoclonal
plasma cells, the presence of CRAB symptoms and/or myelo-
ma-defining events. Bone marrow’s microenvironment and
nuclear factor-kB (NF-kB) signaling pathway play a relevant
role in MM pathogenesis, constituting now therapeutic targets.
Furthermore, oxidative stress has been observed in several
hematopoietic malignancies, being the NF-kB and the nuclear
factor (erythroid-derived 2)-like 2 (NRF2) the two key
transcription factors (TFs) that regulate the cellular responses
to oxidative stress and inflammation. This work aims to elucidate
the importance of NF-kB and NRF2 axis in the MM biology and
response to treatment.
Thirty patients with MM were enrolled in the study and the
bone marrow cell populations were evaluated by flow cytometry.
The expression levels of NF-KB and its phosphorylated form, and
of NRF2were determined in the different cell populations, with a
special focus on plasm cells, using flow cytometry. The TFs
expression levels were correlated with clinical and laboratorial
data.
Our cohort of 30 MM patients included 12 females and 18
males, with a median age at diagnosis of 62 years (32–74). Two
patients at diagnosis, fourteen patients in remission and fourteen in
relapse. According with international scoring system (ISS) 12
patients (40%) were in stage I, 10 patients (33.3%) in stage II, 5
patients (16.7%) in stage III and the ISS was not determined in 3
patients (10%). In tumor plasma cells, we observed at diagnosis a
higher percentage of cells expressing NRF2 (22.9±22.7) and NF-
kB (21.7±21.5) comparing with observed at remission time-point
(NRF2: 7.0±3.1; NF-kB: 4.3±1.5). An intermediated expression
was observed (NRF2: 12.2±4.3; NF-kB: 6.5±1.8) in samples at
relapse. The increase of tumor plasma cells expressing these TFs
was also associated with the presence of bone lesion and kappa
light-chains. All the other bone marrow populations expressed
these TFs, but higher expression was observed in granulocytes.
Our preliminary data suggest an association of NRF-2 andNF-
kB expression with MM pathophysiology and disease stage.
This work was supported by CIMAGO and NRC-LPCC/
CIMAGO grant.
STAT5 – A new therapeutic target in acute lymphoblastic
leukemia?
Joana Jorge1,2,3, Alexandre Estevam1, Raquel Alves1,2,3,
Beatriz Lapa1,2,3, José Manuel Nascimento-Costa2,3,4, Ana
Cristina Gonçalves1,2,3, Ana Bela Sarmento-Ribeiro1,2,3,5
1Laboratory of Oncobiology and Hematology and University
Clinic of Hematology, Faculty of Medicine of University of
Coimbra (FMUC), Coimbra, Portugal;2iCBR-Coimbra Institute
for Clinical and Biomedical Research – Area of Environment,
Genetics and Oncobiology (CIMAGO), Faculty of Medicine,
University of Coimbra, CIBB - Center for Innovative Biomedicine
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Clinical AcademicCenter of Coimbra, Portugal;4University Clinic
of Oncology/Faculty of Medicine of University of Coimbra
(FMUC), Coimbra, Portugal;5Clinical Hematology Department/
Centro Hospital e Universitário de Coimbra, Coimbra, Portugal
The signal transducer and activator of transcription (STAT)
family members regulate the transcription of multiple genes
involved in cell survival, proliferation, differentiation and
apoptosis. Deregulation of STATs was associated with several
hematological neoplasias such as acute lymphoblastic leukemia
(ALL). ALL is a malignant transformation and proliferation of
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hyperdevelopment or mandibular hypodevelopment which leads
to a class II of Angle occlusal relationship.
Effect of orthodontic tooth movement on dental pulp
mineralization process.
José Pedro Martinho1, Eurico Serrano2, João Garcia3, João
Brochado3, Luísa Maló4
1Institute of Endodontics of Faculty of Medicine, University of
Coimbra, Portugal;2Biochemistry Department, Faculty of Sci-
ence and Technology, University of Coimbra, Portugal;3
Dentistry Department, Faculty of Medicine, University of
Coimbra, Portugal;4 Institute of Orthodontics of Faculty of
Medicine, University of Coimbra, Portugal.
Aims/Context: Dental pulp stem cells in response to a variety
of environmental signals are capable of generating new stem cells
and engage in specific differentiation pathways, of which the
odontoblastic is essential for the maintenance of pulp homeosta-
sis. As a survival mechanism, the pulp-dentin system responds to
an aggression not only with proliferation and differentiation of
dental pulp stem cells but also with the production of mineralized
tissue inside the dental pulp. The aim of this study was to
determine the effects of orthodontic forces on the dental pulp
mineralization process.
Methods: Pre-molars subjected to orthodontic forces were
divided into 4 groups (control; and 1, 2 and 3 weeks of
orthodontic movement) and subjected to histologic and immu-
nohistochemistry analysis with specific mineralized tissue anti-
bodies Osteopontin and Osteocalcin.
Results: At weeks 2 and 3 was observed the formation of
mineralized tissue in the dental pulp; and an inflammatory
response with differentiation of adipose tissue. The expression of
Osteopontin was the same in all experimental groups, while was
observed an increase in the expression of Osteocalcin at week 3.
Conclusions: In relation to Osteopontin, it can be infer that the
dental pulp expresses this protein as an attempt to contradict the
defense mechanism that is the pulp mineralization. The increased
expression of osteocalcin in week 3 allow us to conclude that it is
at this later period that the differentiated odontoblast-like cells
exist in greater numbers and are metabolically active.
Using less than 10% formalin fixed tissue samples in vimentin
immunohistochemical detection: possible impact on oncobio-
logical analysis?
Raquel Graça-Lopes1, Mariana Almeida1, Manuela Novo2,
João Palma1,3, Mário Matos1, Carina Ladeira1, Amadeu Borges-
Ferro1
1Escola Superior de Tecnologia da Saude de Lisboa, Instituto
Politécnico de Lisboa. Portugal;2Hospital Fernando Fonseca E.
P.E., Amadora, Portugal;3Hospital de Vila Franca de Xira, Vila
Franca de Xira, Portugal
Context: There are very few circumstances where the diagnosis
of malignancy is made in the absence of histopathological
confirmation. For prognosis and therapeutic guidance, it is also
essential to support all decisions with knowledge of the
oncobiology provided by immunohistochemistry and other
molecular methodologies. Regarding this goal, it is essential to
obtain/preserve adequate diagnostic material. In case of tissue
samples, the most widely used fixative is 10% neutral buffered
formalin. However, this concentration is not supported by
consistent scientific evidence.
Aim: To compare immunohistochemical results considering
less than 10% formalin concentrations, in order to support the
proper use of this reagent and also to explore the possibility of
decreasing the formalin use, since its toxicity is known.
Methods: Three formalin concentrations (10; 7,5; 2,5%) and
70% ethanol (representing non-formalin fixation) were used to
fix, for 48hours at room temperature, similar sized human
placenta samples, with a cold ischemia time of 15 minutes. For
each fixative, 30 paraffin blocks were prepared, which, after
sectioning, were subjected to vimentin (NCL-L-VIM-V9) immu-
nohistochemical detection (Ventana Benchmark GX - OptiView
DAB), has this structural protein is commonly used as a fixation
quality biomarker. Immunohistochemical results were assessed
by two experts using the Global Immunohistochemistry Score
(GIS) providing a 0–100 points score. The GIS results were
analysed using descriptive statistics and Kruskal-Wallis test with
pairwise comparison.
Results: The results were (mean-standard deviation): 2,5%
formalin (90,10–6,94); 7,5% formalin (86,77–7,22); 10% formalin
(82,94–9,62); 70% ethanol (84,67–9,49). The Kruskal-Wallis test
revealed statistical differences between 2,5% formalin and all the
other samples (p<0,05). The internal consistency between the two
observers was considered satisfactory (a=0,72).
Conclusions: Results sustain that 2.5% formalin provided best
immunohistochemical results in this context. Even considering
the exploratory type of this research, it is possible to consider the
reduction of formalin concentration used in fixation.
Improving peripheral venous catheterization-related outcomes
in oncology patients: an action research study in Portugal
Paulo Santos-Costa1,2, Liliana B. Sousa2, Cristina Costeira3,
Filipe Santos3, Anabela Salgueiro-Oliveira2, Pedro Parreira2,
Margarida Vieira4, João Graveto2
Universidade Católica Portuguesa - Instituto de Ciências da
Saude, Porto, Portugal,2Unidade de Investigação Ciências da
Saude: Enfermagem da Escola Superior de Enfermagem de
Coimbra, Portugal;3Instituto Portugues de Oncologia de
Coimbra Francisco Gentil, E.P.E., Aptd. 2005 Coimbra,
Portugal4Centro de Investigação Interdisciplinar em Saude,
Universidade Católica Portuguesa, Porto, Portugal
Aims/context: Peripheral intravenous catheterization (PIVC) is
not a risk-free procedure with complications rates as high as
90%. In the literature, evidence on the incidence and impact of
such procedure in oncology patients is scarce. Thus, we intend to
identify current clinical practices and technologies in use during
the PIVC of oncology patients. Based on the initial findings, a
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multimodal intervention will be implemented and its effectiveness
in reducing associated complications will be assessed.
Methods: Through Action Research method, three major
phases of activities were defined: i) Planning phase, where current
PIVC-related practices, technologies in use and complication
rates will be identified; ii) Action phase, with the implementation
of a multimodal intervention to align PIVC-related practices to
the latest scientific evidence; iii) Reflection phase, discussing the
project’s results with the ward team and the institution’s board.
This study will be conducted at the Instituto Português de
Oncologia de Coimbra following approval from the Administra-
tion Board and Ethical Committee.
Results: An Observational Prospective study is being carried
with the support of the general surgical department’s medical
consultant and nursing manager. Clinically stable patients age
≥18 years and with the indication for PIVC insertion for a period
≥24hours are being recruited for study participation. Patients
who received immunosuppressive or chemo/radiotherapy treat-
ment in the three months prior to the study recruitment date are
automatically excluded. Daily data collection is being undertaken
focused on PIVC-related variables (e.g., gauge, selected site) and
outcomes (e.g., phlebitis and infiltration rates), patient demo-
graphical and clinical variables.
Conclusions:We expect that the multimodal intervention to be
developed substantiates higher quality and safety standards
during PIVC-related care provision, with the potential to be
replicated in other oncology settings.
Pain Evaluation for Health Professionals - Impact on Patient
Care
Rui Garcia1, Cristina Santos1, Catarina Rodrigues1
1Haematology Service- Centro Hospitalar e Universitário de
Coimbra
Introduction and Goals: Pain is a symptom that affects the
quality of life of millions of people around the world, constituting
the main reason for the demand for health care by the population
It is a morbidity and mortality factor associated with longer-
lasting hospital stays and increased consumption of health
resources.
In this study tha authors aim to:
1) Analyze the use of tools for pain assessment in a hospital
environment
2) Document the main analgesic strategies used
3) Evaluate the quality of the approach of the hospitalized
patient with pain by health professionals
Methods: A retrospective observational cross-sectional study
(1 month) was designed. The study population included 2 groups
N1=125 health professionals from an hospital service
N2=192 patients hospitalized for at least 72 hours
Exclusion criteria considered: length of stay less than 72h,
complete absence of procedural records
Statistical analysis: calculation of frequencies and medians
Results: Less than half of the reviewed clinical files (47.4%
medical records and 45.3% nursing records) document pain on
admission and less than one-sixth of the clinical records (13.5%)
report the type of analgesia actually administered and the
therapeutic response obtained-
Only about half of the therapeutic tables (50.5%) include
indications for assessing the patient’s pain during hospitalization,
although 11.5% have prescription painkillers
Most hospitalized patients experience pain during hospitaliza-
tion and pain complaints have been poorly documented,
conditioning their therapeutic approach
Best practices in addressing pain have been inconsistently
applied
Conclusion: The proper assessment and the institution of
individualized analgesia that contemplates the different aspects of
pain should be considered as an integral part of daily clinical
routines
An integrated approach to pain is essential for defining
analgesic strategies, improving the quality of care provided to
inpatients
Study shows the need to implement surveys and pain
assessment scales for hospitalized patients in the clinical interview
and adequately document complaints whenever pain is con-
firmed, it should be continuously monitored and treated.
Multidisciplinary meeting to support family of oncological
patients
Cristina Santos1,Catarina Rodrigues1, Rui Garcia1
1Serviço de Oncologia -Centro Hospitalar e Universitário de
Coimbra
Introduction and Goals: In holistic care for the severely ill
person, we cannot fail to identify family problems and concerns
that will be the key to adapt the person to the disease.
Most of caregivers in palliative care emerge from family. Their
roles have an impact on the life and quality of care provided.
Health teamsmust be aware of these changes and plan supportive
interventions, with measures that prevent the collapse of his life.
The aims are:-Hold multidisciplinary meeting with profes-
sionals and family.
-Assess family needs, opportunities and resources to support
safe home return.
-Promote symptomatic relief and fulfillment of the patient’s
wishes.
Methodology: An exploratory study was elaborated, with
quantitative data. A multidisciplinary premeeting questionnaire
was applied to all families of patients admitted to oncology
service and at the end of meeting a new questionnaire was
applied. Responses were voluntary, anonymous and confidential.
Results: Fifty-two pre and post meeting questionnaires were
applied. Regarding pre meeting questions 86% of the families
wanted information about the patient’s clinical situation and how
to take care of patient. In post meeting questions 100% of the
families expressed satisfaction in holding the meeting, consider-
ing it a necessity and an asset and a perk.
This multidisciplinary meeting clarified, reassured and relieved
family’s anguish. At the end 90% of the families did not express
doubts or difficulties regarding how to take care of their patient,
allowing safe return home.
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It was evidenced that they are clear about the patient’s
condition and how to intervene according to the needs of each
moment. Families also highlight the fact that this is a meeting
with a multidisciplinary team in which the family is considered an
active member.
Conclusion: The families acquired knowledge and skills
allowing them to make decisions about how to care the patient,
with fewer referrals to palliative care facilities. The results
confirm the need of family involvement in care process of their ill
member, contributing to improvement of the quality of life of all
ando f the care provided, namely with the satisfaction of the
patient’s wishes.
The use of chlorhexidine gluconate dressings in central venous
catheters
Catarina Rodrigues1, Cristina Santos1, Micaela Rodrigues1
1Haemathology Service- Centro Hospitalar e Universitário de
Coimbra
Introduction: The use of chlorhexidine gluconate dressings is
recommended to protect the insertion site of short-term central
venous catheters (CVC), and is specifically indicated to reduce
infections associated with CVC. The dressing consists of
transparent adhesive film and a gel pad impregnated with 2%
chlorhexidine gluconate, an antiseptic agent with broad spectrum
antimicrobial / antimycotic activity, and also contains a plastic
fixing device, on a breathable base in adhesive. silicone, less
aggressive to the skin, which when replacing the fixation points
reduces the entrance doors to microorganisms.
Methods: This study aims to evaluate the effectiveness of using
chlorhexidine gluconate dressings in CVC, as well as its
importance in reducing CVC-associated infection in a clinical
hematology service. This is a descriptive and quantitative study,
with a non-probabilistic sample, with a number of 32 patients,
between April and June of 2019. The questionnaires were
completed by the nurseswho performed the treatment at the CVC
insertion site according to the training performed. All ethical
procedures inherent to the study were followed.
Results: The results revealed that patients had a predominant
pathology of multiple myeloma, with the subclavian vein being
the preferred site for CVC insertion. The dressings applied in
comparison with the semi-permeable transparent polyurethane
films, placed previously, allowed to increase the replacement
frequency to 7 days in half of the evaluations. In the rest, the
dressing was replaced because it was damp, loose or dirty and
inflammatory signs were observed in 31.8% of the evaluations
compared to the previous ones, which was 50%.
Conclusion: The use of chlorhexidine gluconate dressings
requires less manipulation, therefore less risk of infection. The
gel allows a continuous application of chlorhexidine gluconate
at the puncture point and as they are transparent dressings they
allow visualization of the insertion site without removing it.
The gel was able to absorb liquids (sweat, blood or exudate)
without interfering with antiseptic activity. In turn, the
fixation device allows strong adhesion and is less aggressive
to the skin.
ROS1 positive Non-Small Cell Lung Cancer clinical case
Sónia Silva1, Salvato Feijó1
1Centro Hospitalar de Leiria
Introduction: The identification of molecular targets has
become indispensable for the treatment of lung cancer and has
revolutionized its prognosis. However, the percentage of mutated
patients who can benefit from these therapies is low. ROS1 gene
rearrangement is present in only 1–3% of the lung adenocarci-
nomas.
Clinical case: A 67 year old non-smoker woman presented to
the emergency department with dyspnea and cough for the last
3 months. She had a chest CT scan with a 41x47 tumor lesion in
the left lower lobe, homolateral pleural effusion and multiple
adenopathies.
Bronchoscopy (27/07/2018) revealed tumor lesion with
obliteration of the left lower lobe bronchus. Biopsies revealed
lung adenocarcinoma.
On August 14, she was hospitalized for serious worsening
of dyspnea. CT angiography showed a significant worsening
of the left hilar mass with left principal bronchus obliteration
with atelectasis, worsening of the pleural effusion and
bilateral lung metastases. She repeated bronchofibroscopy
(21/08) with significant worsening with infiltration of
practically all left main bronchus and total obstruction of
the lobar orifices.
Awaiting molecular study she started chemotherapy with
cisplatin and pemetrexed on August 23 and was discharged with
PS2 and on oxygen therapy. Revealing to be ROS1 positive she
started Crizotinib on 28/09. After 2 weeks of treatment, there was
significant radiological and symptomatic improvement (PS1 and
nomore need for oxygen therapy). Currently, more than one year
after starting therapy, she has PS 0 and CT scan revealing
complete response.
Conclusion: We describe a case of an agressive lung cancer
with complete response maintained after 1 year of therapy.
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